Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » 10X Genomics

10X Genomics

 

10x Genomics, Inc. is an American company incorporated in 2012 that develops and manufactures integrated systems for whole genome sequencing, exome sequencing and single cell transcriptomics. Its headquarters are located in Pleasanton, California.

 

10X Genomics Company Profile  

 

President & CEO: Serge Saxonov

CEO photo:

 10X Genomics CEO photo - Serge Saxonov

Website: http://10xgenomics.com

Headquarters: Pleasanton, CA

10x Genomics employees: 101-250

Funding: $113M USD

Founded: 2012

Founders: Serge Saxonov, Ben Hindson


 

10x Genomics News 

Sep 18, 2020

New Products Posted to GenomeWeb: Sanford Burnham Prebys, 10x Genomics, Bio-Rad, More

Sep 11, 2020

10x Genomics Prices Upsized $440M Public Offering

The firm is offering an additional 500,000 shares of Class A stock, bringing the total to 4 million shares, offered at $110 per share.

Sep 09, 2020

10x Genomics to Sell 3.5M Shares in Public Offering

The single-cell and spatial genomics firm is seeking to raise more money from the markets a year after its $410.8 million IPO.

Aug 11, 2020

10x Genomics Q2 Revenues Fall 23 Percent but Beat Wall Street Estimates

The firm's $42.9 million in total revenues and $.41 loss per share for the second quarter both beat the average analyst estimates.

Aug 03, 2020

US Appeals Court Lifts Injunction on 10x Genomics' Linked-Reads, Single-Cell CNV Assays

The court also ordered a new trial to determine if 10x's products infringe reconstructed patents held by Bio-Rad Laboratories.

Jul 30, 2020

Double-Barcoded Single-Cell Library Prep Solves Index-Hopping Issues, Lowers Sequencing Costs

Premium

Two companies offering droplet-based single-cell RNA sequencing sample prep, 10x Genomics and 1Cellbio, have launched dual-indexed library preparation products.

Jul 21, 2020

10x Genomics Awarded Exclusive License to Harvard Droplet IP by Massachusetts Court

Codefendant 1Cellbio, an instrument maker that had obtained a co-exclusive license to the patents, said it plans to appeal the court's declaration.

Jul 13, 2020

Single-Cell Sequencing Reveals How Severe COVID-19 Exacerbated by Type I Interferons

Researchers from South Korea used 10x Genomics' scRNA-seq platform to also find type I IFN-driven inflammatory features in patients with severe influenza.

Jun 15, 2020

Genome In a Bottle Consortium Releases Structural Variant Calling Benchmark Data

Premium

The public-private partnership has published a paper on a list of indels larger than 50 bp that is already being used to develop new methods.

Jun 10, 2020

10x Genomics, MilliporeSigma Collaborate on CRISPR Screening Workflow

The firms are targeting a compatible offering for single-cell gene expression screens following CRISPR-based editing, with applications in drug discovery.

Pages

The Scan

This Time, Novavax

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Shortened Visas for Some Students

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

New York's Own Review

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.